Skip to main content
Erschienen in: Journal of Neural Transmission 7/2019

08.04.2019 | Neurology and Preclinical Neurological Studies - Review Article

Mild cognitive impairment in Parkinson’s disease

verfasst von: Saul Martinez-Horta, Jaime Kulisevsky

Erschienen in: Journal of Neural Transmission | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Understanding on the clinical features and neural mechanisms leading to cognitive impairment and dementia in Parkinson’s disease (PD) has notably increased. At time of diagnosis, nearly all PD patients present some degree of cognitive impairment not enough severe as to significantly affect functional independence. However, even mild cognitive changes have a measurable impact to functional capacity in PD. A clinically practical differentiation is based on the importance of executive deficits in the early phases of cognitive impairment in PD and on the evidence stressing the transitional role of posterior–cortical impairment on the progression of PD-MCI to dementia. However, the pattern of cognitive impairment in PD is variable not just to the extents on which are the affected cognitive domains, but also on which are those domains that became affected first. Specific diagnostic criteria for mild cognitive impairment associated with PD (PD-MCI) and dementia (PDD) and operative guidelines for the cognitive assessment have been developed. In the present review, we will describe general notions regarding the mechanisms and the profile of cognitive deterioration in PD, the diagnostic criteria for PD-MCI, and some of the currently recommended assessment approaches.
Literatur
Zurück zum Zitat Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P (2001) Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology 56:730–736CrossRefPubMed Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P (2001) Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology 56:730–736CrossRefPubMed
Zurück zum Zitat Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387–392CrossRefPubMed Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387–392CrossRefPubMed
Zurück zum Zitat Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002) Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET. Brain 125:584–594CrossRefPubMed Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002) Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET. Brain 125:584–594CrossRefPubMed
Zurück zum Zitat Kulisevsky J, Avila A, Barbanoj M, Antonijoan R, Berthier ML, Gironell A (1996) Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson’s disease patients at different levodopa plasma levels. Brain 119(Pt 6):2121–2132CrossRefPubMed Kulisevsky J, Avila A, Barbanoj M, Antonijoan R, Berthier ML, Gironell A (1996) Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson’s disease patients at different levodopa plasma levels. Brain 119(Pt 6):2121–2132CrossRefPubMed
Zurück zum Zitat Kulisevsky J, Garcia-Sanchez C, Berthier ML, Barbanoj M, Pascual-Sedano B, Gironell A, Estevez-Gonzalez A (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson’s disease: a two-year follow-up study of previously untreated patients. Mov Disord 15:613–626CrossRefPubMed Kulisevsky J, Garcia-Sanchez C, Berthier ML, Barbanoj M, Pascual-Sedano B, Gironell A, Estevez-Gonzalez A (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson’s disease: a two-year follow-up study of previously untreated patients. Mov Disord 15:613–626CrossRefPubMed
Zurück zum Zitat Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308CrossRefPubMed Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308CrossRefPubMed
Zurück zum Zitat Wang M, Norman JE, Srinivasan VJ, Rutledge JC (2016) Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline. Am J Neurodegener Dis 5:171–177PubMedPubMedCentral Wang M, Norman JE, Srinivasan VJ, Rutledge JC (2016) Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline. Am J Neurodegener Dis 5:171–177PubMedPubMedCentral
Metadaten
Titel
Mild cognitive impairment in Parkinson’s disease
verfasst von
Saul Martinez-Horta
Jaime Kulisevsky
Publikationsdatum
08.04.2019
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 7/2019
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-019-02003-1

Weitere Artikel der Ausgabe 7/2019

Journal of Neural Transmission 7/2019 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Review Article

Hypersalivation: update of the German S2k guideline (AWMF) in short form

Neurology and Preclinical Neurological Studies - Review Article

Neuropsychiatric aspects of Parkinson’s disease

Neurology and Preclinical Neurological Studies - Review Article

Management of delirium in Parkinson’s disease

Neurology and Preclinical Neurological Studies - Review Article

Sleep–wake and circadian disturbances in Parkinson disease: a short clinical guide

Neurology and Preclinical Neurological Studies - Original Article

Disease stage dependency of motor and non-motor fluctuations in Parkinson’s disease

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.